Happy holidays from Broadstreet
As another busy and productive year draws to a close here at Broadstreet, we wanted to take a few minutes to wish our friends, clients and colleagues a safe and…
New research from Broadstreet and colleagues on how disease-free survival as a measure of treatment outcome is viewed by cancer survivors
Early clinical successes are becoming more common in oncology; and as a result, there is a need for endpoints that can meaningfully describe outcomes among treated patients. In cases where…
Broadstreet at virtual ISPOR Europe 2021
Broadstreet is pleased to be presenting several posters at this year’s virtual ISPOR Europe meeting. USE OF REAL-WORLD EVIDENCE TO EVALUATE INFLIXIMAB BIOSIMILARS: A SCOPING REVIEW Antoinette Cheung,1 Lauren Powell,1…
Members of the Broadstreet team collaborate on new publication
Broadstreet is pleased to be contributing to a greater understanding of the contemporary burden of Duchenne muscular dystrophy (DMD) with this new publication in the Journal of Managed Care and…
Pharmavoice feature on new research from Broadstreet and BI
Broadstreet, collaborating with Bonnie Donato (Boehringer Ingelheim), has been looking at how high deductible health plans affect access to care in the US. Ahead of our upcoming journal publication on…
New migraine publication from members of the Broadstreet team
Our collaborative work with the Biohaven team on migraine continues to reveal new insights about the condition and we are pleased to have had some of our most recent research…
Drumroll … Announcing the Broadstreet HEOR Website Renovation
We’re very excited to announce the launch of our new website, a beautifully designed digital home that reflects who we are, what we do and how we’ve evolved over the…
Seeing the evidence of COVID vaccine efficacy
Because we are epidemiologists, we often have people asking us questions about COVID-19 in general and about the vaccines in particular. Like many others, we have been awed and grateful…
Broadstreet HEOR and Sprout Health Solutions publish new research that reinforces complex treatment burden for hemophilia A
VANCOUVER, BC, July 20 – Broadstreet Health Economics & Outcomes Research (HEOR), with Sprout Health Solutions, announced the publication of a study in Patient Preference and Adherence that provides new…
A new publication for the Broadstreet team in the Orphanet Journal of Rare Diseases
We are thrilled to be working with amazing collaborators to help understand the burden of Duchenne muscular dystrophy (DMD). Here is some of our recent research published in the Orphanet Journal…